Results 91 to 100 of about 150,085 (313)
Factors associated with statin treatment for the primary prevention of cardiovascular disease in people within 2 years following diagnosis of diabetes in Scotland, 2006-2008 [PDF]
Aim: To describe characteristics associated with statin prescribing for the primary prevention of cardiovascular disease in people with newly diagnosed diabetes.
Scottish Diabetes Research Network (SDRN) Epidemiology group +27 more
core +1 more source
Aims To determine the prevalence of non‐adherence to antihypertensive medicines and to identify demographic and behavioral factors associated with non‐adherence in subjects enrolled in the May Measurement Month (MMM) 2023, as part of the permanent public health action Hunting the silent killer.
Valerija Bralić Lang +12 more
wiley +1 more source
Aims The aim of this study was to introduce a new assessment method for pharmacy students' real‐life competence in reviewing medications after obligatory advanced‐level practical internship in Finland. Methods The new medication review (MR) competence assessment method consisted of (1) a self‐assessment by pharmacy students and (2) a performance ...
Katja Leiman +5 more
wiley +1 more source
BackgroundCurrently, there remains substantial controversy in research regarding whether the concomitant use of colchicine and statins increases the occurrence of rhabdomyolysis, warranting further substantiation.ObjectiveThis study aimed to identify the
Sha Zhang +4 more
doaj +1 more source
pub-statins-br: Paper revision with new captions
Analysis code incl. data set for Tervonen et al.: "Applying Multiple Criteria Decision Analysis (MCDA) to Comparative Benefit-Risk Assessment - Choosing Among Statins in Primary Prevention ...
Tommi Tervonen, Gert van Valkenhoef
core +1 more source
Abstract Introduction Active surveillance of adverse events using healthcare data is emerging as complementary to the monitoring of spontaneous reports and stand‐alone pharmacoepidemiologic studies. The risk of urinary tract infections (UTIs) was listed as a special warning for sodium‐glucose cotransporter‐2 inhibitors (SGLT2is) when marketed in Europe
Haoxin Le +5 more
wiley +1 more source
pub-statins-br: Paper revision with new analysis
Analysis code incl. data set for Tervonen et al.: "Applying Multiple Criteria Decision Analysis (MCDA) to Comparative Benefit-Risk Assessment - Choosing Among Statins in Primary Prevention ...
Tommi Tervonen, Gert van Valkenhoef
core +1 more source
Abstract Purpose To quantify how often creatine kinase (CK) is measured after newly elevated aminotransferases in statin users, and whether absent CK data are associated with gastroenterology (GI) referrals. Methods Retrospective chart review of adult outpatients on statins with a first alanine/aspartate aminotransferase (ALT/AST) elevation during a 5 ...
Faris Shweikeh +5 more
wiley +1 more source
Highly variable biological effects of statins on cancer, non-cancer, and stem cells in vitro
Statins, the drugs used for the treatment of hypercholesterolemia, have come into the spotlight not only as chemoadjuvants, but also as potential stem cell modulators in the context of regenerative therapy.
Helena Gbelcová +9 more
doaj +1 more source
Pharmacoepidemiology of statins
The evaluation of the real-life benefits and risks of statins in population is a major pharmacoepidemiological issue, given their widespread use for cardiovascular prevention. The purpose of this review was not to be exhaustive but to show the contributions of pharmacoepidemiology for various aspects of the evaluation of statins such as real-life drug ...
Julien, Bezin, Nicholas, Moore
openaire +3 more sources

